NEW YORK (Reuters Health) – Results of a clinical trial of the new, long-acting neuraminidase inhibitor laninamivir octanoate show that it is not inferior to oseltamivir in treating…
The first annual Mobile Health Expo was held on October 19-21, 2010 in Las Vegas, NV. The conference was attended by leaders in areas including mobile medicine, wireless…
Joseph Ramagnulo, MD, MSc, FRCPC, Associate Professor Gastroenterology and Hepatology, Medical University of South Carolina, discusses abdominal pain that cannot be diagnosed and a study he is coducting…
Francis G. Spinale, MD, PhD, Medical University of South Carolina, discusses controlling BP using biomarkers to tell us if we should add on antihypertensive therapy. Related Reading Angiotensin-(1-7)…
Charles E. Argoff, MD, Professor of Neurology and Director of the Comprehensive Pain Center, Albany Medical Center, describes the side effect profile of topical NSAIDs, which is exactly…
Charles E. Argoff, MD, Professor of Neurology and Director of the Comprehensive Pain Center, Albany Medical Center, describes new guidelines for pain management in geriatrics. The most reasonable…
NEW YORK (Reuters Health) – In patients with mixed dyslipidemia, fenofibric acid added to atorvastatin and ezetimibe results in improved lipid and non-lipid levels, according to a report…
Sandeep Jauhar, MD, cardiologist and author, describes, via his office webcam, the experience of being an intern and the subject of his book, Intern: A Doctor’s Initiation, a…
NEW YORK (Reuters Health) – For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (TNF) agents appears to reduce their risk of cardiovascular events, including MI…
NEW YORK (Reuters Health) – A population-based study from Scotland shows that fewer than one in every 100 patients with subclinical hyperthyroidism will progress to overt hyperthyroidism. In…